Literature DB >> 8734733

Characteristics of invasive bladder cancers: histological and molecular markers.

M Liebert1, J Seigne.   

Abstract

Changes in gene expression permit the emergence of clones of cancer cells with biological properties that enable invasion and metastasis. We present in this article an overview of the variety of genetic and antigenic markers that have been reported for invasive bladder cancer. Although the prognostic and diagnostic usefulness of many of these markers in invasive bladder cancer remains to be fully evaluated, this review will serve as a resource for the clinician on the current state of the field. Alterations in the biology and genetics of cells no doubt contribute to the processes of invasion and metastasis and are likely to provide important, useful information for future identification and management of the patient with invasive bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734733

Source DB:  PubMed          Journal:  Semin Urol Oncol        ISSN: 1081-0943


  10 in total

Review 1.  Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).

Authors:  Courtney Pollard; Steven C Smith; Dan Theodorescu
Journal:  Expert Rev Mol Med       Date:  2010-03-25       Impact factor: 5.600

2.  Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

Authors:  Koji Ueno; Hiroshi Hirata; Shahana Majid; Soichiro Yamamura; Varahram Shahryari; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  Mol Cancer Ther       Date:  2011-11-04       Impact factor: 6.261

3.  MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koji Ueno; Varahram Shahryari; Z Laura Tabatabai; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2011-11-01       Impact factor: 4.944

4.  Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.

Authors:  P J Grippo; E P Sandgren
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).

Authors:  Li-Mei Chen; Nicole J Verity; Karl X Chai
Journal:  BMC Cancer       Date:  2009-10-22       Impact factor: 4.430

6.  c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.

Authors:  Keiji Shimada; Mitsutoshi Nakamura; Eiwa Ishida; Tomonori Higuchi; Motoyoshi Tanaka; Ichiro Ota; Noboru Konishi
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

7.  Utility of SAM68 in the progression and prognosis for bladder cancer.

Authors:  Zhiling Zhang; Chunping Yu; Yonghong Li; Lijuan Jiang; Fangjian Zhou
Journal:  BMC Cancer       Date:  2015-05-06       Impact factor: 4.430

Review 8.  Tumor heterogeneity in muscle-invasive bladder cancer.

Authors:  Ho Won Kang; Wun-Jae Kim; Woonyoung Choi; Seok Joong Yun
Journal:  Transl Androl Urol       Date:  2020-12

9.  Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

Authors:  Hiroshi Hirata; Koji Ueno; Varahram Shahryari; Yuichiro Tanaka; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.

Authors:  Yidong Cheng; Xiaolei Zhang; Peng Li; Chengdi Yang; Jinyuan Tang; Xiaheng Deng; Xiao Yang; Jun Tao; Qiang Lu; Pengchao Li
Journal:  Onco Targets Ther       Date:  2016-08-16       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.